Inhibition of Specificity Protein 1 Is Involved in Phloretin‐Induced Suppression of Prostate Cancer
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 1358674
Abstract
Phloretin is a flavonoid existed in various plants and has been reported to possess anticarcinogenic activity. However, the anticancer mechanism of phloretin in prostate cancer (PCa) remains unclear. Here, our in vitro and in vivo experimental data demonstrate that phloretin inhibits the phosphorylation and the activation of EGFR and then inhibits its downstream PI3K/AKT and MEK/ERK1/2 pathways in PCa cells. Inhibition of these two pathways further decreases expression of Sp1 by inhibiting Sp1 gene transcription, induces degradation of Sp1 protein by inhibiting GSK3β phosphorylation, suppresses nucleolin‐enhanced translation of Sp1 mRNA by inhibiting nucleolin phosphorylation, and directly inactivates transcription activity of Sp1. Inhibition of Sp1 subsequently decreases the expression of Sp3/4, VEGF, and Survivin and then upregulates apoptosis‐related proteins and downregulates cell cycle‐related proteins in PCa cells. Finally, phloretin treatment in PCa cells induces cell growth inhibition and apoptosis, suggesting that phloretin may be an effective therapy compound in the treatment of prostate cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81872104, 81472415, 81772732)
This publication has 48 references indexed in Scilit:
- RNA-binding protein nucleolin in diseaseRNA Biology, 2012
- Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factorsBMC Cancer, 2011
- Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAsNucleic Acids Research, 2011
- NucleolinCommunicative & Integrative Biology, 2011
- Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulationJournal of Biological Chemistry, 2010
- Apoptosis by dietary agents for prevention and treatment of prostate cancerEndocrine-Related Cancer, 2010
- Thiazolidinediones Mimic Glucose Starvation in Facilitating Sp1 Degradation through the Up-Regulation of β-Transducin Repeat-Containing ProteinMolecular Pharmacology, 2009
- Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3,11‐dioxo‐18β‐olean‐1,12‐dien‐30‐oate in colon cancer cellsInternational Journal of Cancer, 2009
- M-CSF Signals through the MAPK/ERK Pathway via Sp1 to Induce VEGF Production and Induces Angiogenesis In VivoPLOS ONE, 2008
- Curcumin Decreases Specificity Protein Expression in Bladder Cancer CellsCancer Research, 2008